210 related articles for article (PubMed ID: 30965067)
1. Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation.
Balassa K; Salisbury R; Watson E; Lubowiecki M; Tseu B; Maouche N; Jeffery K; Misbah SA; Benamore R; Rowley L; Barton D; Pawson R; Danby R; Rocha V; Peniket A
J Infect; 2019 Jun; 78(6):461-467. PubMed ID: 30965067
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
[TBL] [Abstract][Full Text] [Related]
3. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
[TBL] [Abstract][Full Text] [Related]
4. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.
Shah DP; Ghantoji SS; Shah JN; El Taoum KK; Jiang Y; Popat U; Hosing C; Rondon G; Tarrand JJ; Champlin RE; Chemaly RF
J Antimicrob Chemother; 2013 Aug; 68(8):1872-80. PubMed ID: 23572228
[TBL] [Abstract][Full Text] [Related]
5. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.
Beaird OE; Freifeld A; Ison MG; Lawrence SJ; Theodoropoulos N; Clark NM; Razonable RR; Alangaden G; Miller R; Smith J; Young JA; Hawkinson D; Pursell K; Kaul DR
Transpl Infect Dis; 2016 Apr; 18(2):210-5. PubMed ID: 26923867
[TBL] [Abstract][Full Text] [Related]
6. Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients.
Gorcea CM; Tholouli E; Turner A; Saif M; Davies E; Battersby E; Dignan FL
J Hosp Infect; 2017 Feb; 95(2):214-217. PubMed ID: 28077243
[TBL] [Abstract][Full Text] [Related]
7. A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study.
Piñana JL; Hernández-Boluda JC; Calabuig M; Ballester I; Marín M; Madrid S; Teruel A; Terol MJ; Navarro D; Solano C
Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28544152
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients.
Damlaj M; Bartoo G; Cartin-Ceba R; Gijima D; Alkhateeb HB; Merten J; Hashmi S; Litzow M; Gastineau D; Hogan W; Patnaik MM
Transpl Infect Dis; 2016 Apr; 18(2):216-26. PubMed ID: 26909896
[TBL] [Abstract][Full Text] [Related]
10. Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients.
Molinos-Quintana A; Pérez-de Soto C; Gómez-Rosa M; Pérez-Simón JA; Pérez-Hurtado JM
Bone Marrow Transplant; 2013 Feb; 48(2):265-8. PubMed ID: 23000643
[TBL] [Abstract][Full Text] [Related]
11. Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons.
Falsey AR; Koval C; DeVincenzo JP; Walsh EE
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28054734
[TBL] [Abstract][Full Text] [Related]
12. Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic malignancy and haematopoietic stem cell transplant recipients: a systematic review and meta-analysis.
Manothummetha K; Mongkolkaew T; Tovichayathamrong P; Boonyawairote R; Meejun T; Srisurapanont K; Phongkhun K; Sanguankeo A; Torvorapanit P; Moonla C; Plongla R; Kates OS; Avery RK; Nematollahi S; Permpalung N
Clin Microbiol Infect; 2023 Oct; 29(10):1272-1279. PubMed ID: 37116860
[TBL] [Abstract][Full Text] [Related]
13. Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection.
Azzi JM; Kyvernitakis A; Shah DP; El Haddad L; Mahajan SN; Ghantoji SS; Heredia-Ariza E; Chemaly RF
J Antimicrob Chemother; 2018 Nov; 73(11):3162-3169. PubMed ID: 30113677
[TBL] [Abstract][Full Text] [Related]
14. Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.
Foolad F; Aitken SL; Shigle TL; Prayag A; Ghantoji S; Ariza-Heredia E; Chemaly RF
Clin Infect Dis; 2019 May; 68(10):1641-1649. PubMed ID: 30202920
[TBL] [Abstract][Full Text] [Related]
15. Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation.
Casey J; Morris K; Narayana M; Nakagaki M; Kennedy GA
Bone Marrow Transplant; 2013 Nov; 48(12):1558-61. PubMed ID: 23912665
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.
Vakil E; Sheshadri A; Faiz SA; Shah DP; Zhu Y; Li L; Kmeid J; Azzi J; Balagani A; Bashoura L; Ariza-Heredia E; Chemaly RF
Transpl Infect Dis; 2018 Dec; 20(6):e12994. PubMed ID: 30195271
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus infection following hematopoietic stem cell transplantation.
Small TN; Casson A; Malak SF; Boulad F; Kiehn TE; Stiles J; Ushay HM; Sepkowitz KA
Bone Marrow Transplant; 2002 Feb; 29(4):321-7. PubMed ID: 11896429
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients.
Houist AL; Bondeelle L; Salmona M; LeGoff J; de Latour RP; Rivière F; Soler C; Houdouin V; Dalle JH; Robin C; Fourati S; Griscelli F; Coman T; Chevret S; Bergeron A
Bone Marrow Transplant; 2021 Dec; 56(12):3032-3041. PubMed ID: 34548625
[TBL] [Abstract][Full Text] [Related]
19. Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients.
Marcelin JR; Wilson JW; Razonable RR;
Transpl Infect Dis; 2014 Apr; 16(2):242-50. PubMed ID: 24621016
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus infections in children with cancer.
Chemaly RF; Ghantoji SS; Shah DP; Shah JN; El Taoum KK; Champlin RE; Nunez CA; Mulanovich V; Ariza-Heredia E
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e376-81. PubMed ID: 24327130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
